Healthcare | April 07, 2026
Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
The designation for HCB101covers all forms of gastric cancer, including advanced gastric adenocarcinoma in both HER2-positive and HER2-negative patients
If approved, Ameluz would become the first and only photodynamic therapy (PDT) photosensitizer for sBCC in the US
Subscribe To Our Newsletter & Stay Updated
